United States · FDA National Drug Code directory
verapamil hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-293_c4ac347e-78cd-490d-9047-73a1df2bd717
- Product NDC
- 68462-293
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- verapamil hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110805
- Source listing expiry
- 20261231
Source-listed ingredients
- VERAPAMIL HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-01) · 68462-293-01
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-05) · 68462-293-05
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-293-90) · 68462-293-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →